Citi initiated coverage of Privia Health with a Buy rating and $25 price target. The firm calls Privia its top value-based-care pick, saying it has the most flexible business model and is not overly reliant on one market segment. Privia has the flexibility to move up and down the risk curve across Medicare, Medicaid, and commercial, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRVA:
- Privia Health to Report First Quarter 2024 Results on Thursday, May 9
- Privia Health price target lowered to $37 from $41 at Canaccord
- Barclays starts health care facilities, managed care group with Neutral view
- Privia Health initiated with an Equal Weight at Barclays
- Privia Health price target lowered to $26 from $30 at TD Cowen
